Sukri Asif, Lopes Bruno S, Hanafiah Alfizah
Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Selangor Branch, Puncak Alam Campus, Puncak Alam 42300, Malaysia.
Department of Medical Microbiology, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.
Antibiotics (Basel). 2021 Sep 1;10(9):1061. doi: 10.3390/antibiotics10091061.
The emergence of multidrug-resistant poses a public healthcare threat, particularly in low- and middle-income countries. Recently, the World Health Organization has classified clarithromycin-resistant as high priority in the research and discovery of novel antibiotics. This study was aimed to systematically review the prevalence of primary antibiotic resistance in in Southeast Asian countries (SEAC) and to review current studies of antimicrobial peptides against . We systematically searched through electronic databases of studies conducted on antimicrobial resistance of in SEA countries. Furthermore, we searched articles that conducted studies on antimicrobial peptides, naturally occurring host's defense molecules, against . After a series of screening processes, 15 studies were included in our systematic review. Our analysis revealed that primary resistance of to metronidazole, clarithromycin, and levofloxacin were high in SEAC, although the primary resistance to amoxicillin and tetracycline remains low. Multidrug-resistant are emerging in SE Asian countries. The antimicrobial peptides show promising antibacterial and antibiofilm activity against drug-resistant . The research and discovery of antimicrobial peptides against in SEAC will help in limiting the spread of antimicrobial resistance of .
多重耐药菌的出现对公共卫生保健构成了威胁,尤其是在低收入和中等收入国家。最近,世界卫生组织已将耐克拉霉素菌列为新型抗生素研发的高度优先事项。本研究旨在系统回顾东南亚国家(SEAC)中幽门螺杆菌的原发性抗生素耐药率,并回顾目前针对幽门螺杆菌的抗菌肽研究。我们系统地检索了关于东南亚国家幽门螺杆菌抗菌耐药性的电子数据库研究。此外,我们还检索了关于抗菌肽(天然存在的宿主防御分子)针对幽门螺杆菌的研究文章。经过一系列筛选过程,15项研究被纳入我们的系统评价。我们的分析表明,东南亚国家中幽门螺杆菌对甲硝唑、克拉霉素和左氧氟沙星的原发性耐药率较高,尽管对阿莫西林和四环素的原发性耐药率仍然较低。东南亚国家正在出现多重耐药幽门螺杆菌。抗菌肽对耐药幽门螺杆菌显示出有前景的抗菌和抗生物膜活性。在东南亚国家开展针对幽门螺杆菌的抗菌肽研究与发现将有助于限制幽门螺杆菌抗菌耐药性的传播。